Anjana Harve

More than a third of large organizations have some type of transformation program underway at any given time, yet only 12% produce lasting results. Hear from Michael Mankins and Patrick Litre in Harvard Business Review as they unveil a new model for business transformation based on research with top companies, outlining six key practices for lasting change. #TransformationsThatWork

3

More than a third of large organizations have some type of transformation program underway at any given time, yet only 12% produce lasting results. Hear from Michael Mankins and Patrick Litre in Harvard Business Review as they unveil a new model for business transformation based on research with top companies, outlining six key practices for lasting change. #TransformationsThatWork

18

1 Comment

Thank you, Joe Lennerz! As stewards of real-world patient data, we are passionate about implementing best practices around real-world data management and analytics and partnering with our customers to achieve their RWE and precision medicine aspirations — and ensure that the right patients receive the right treatments at the right time. In this piece Devon Snedden, MGM summarized 4 key takeaways from a recent #ASCO2024 event with an incredible panel of industry luminaries. - Evaluating the diversity of your data sources to ensure they are inclusive and representative data models for the populations you aim to serve to drive greater contextualization, improve health outcomes for underserved populations, and achieve greater health equity. - Partnering with regulators as the next major opportunity for researchers, clinicians and precision medicine experts, especially given the positive potential of AI. - Moving away from legacy “development for many” practices to focus on N-of-1 approach through investments in personalized medicine tools and technologies, enabling the development of high-quality datasets that include detailed patient information, co-mutations, and other comorbidities. - Focusing on data governance as an offense, implementing federated data models and interoperable systems to eliminate silos and enhance data access and usability to ultimately improve diagnostic accuracy, and better-informed therapeutic decisions that enhance patient care. Check it out and let us know how you are leveraging real-world evidence and real-world data. #slalomlifesciences #RWE

14

Emerging technology can be exciting, but the constant buzz can make it hard to identify what's truly important. In this guide I break down three essential tech trends every healthcare leader needs to know. Explore real-world examples of these trends in action, the driving forces behind them and why they deserve your focus. Check out my new Tech trends article

40

1 Comment

My colleagues, Val Panier, together with John Wu, Nithya Vaduganathan, Vladimir Lukic, Margot Bleys, and in partnership with the Massachusetts High Technology Council, Inc. recently released a white paper outlining actionable recommendations to leverage AI for advancing the state’s life sciences and #healthcare sectors. The state of Massachusetts is making significant strides to become a leader in artificial intelligence. The potential for AI in healthcare is immense. Our report details a strategic approach to utilizing AI to improve patient outcomes, promote health equity, and accelerate breakthrough innovations. Learn more here: https://lnkd.in/em_EyTjw

66

2 Comments

Great points in this article about how today everything in the business relies on technology, meaning that the CIO needs to be increasingly strategic and future focused. “The modern CIO in a private equity environment is no longer just a back-office role but a strategic partner capable of driving the business forward.”

14

5 Comments

Note the recent Digital Transformation article from my fellow McKinsey healthcare leaders, to which I had the opportunity to contribute. A few takeaways: - Digital healthcare leaders must embrace agile technology prioritization to keep pace with the accelerating changes in business and technology. - It's crucial to recognize that it's not just financial constraints and legacy technology that can hold us back. Key leadership skills such as data governance, talent development, entrepreneurship, adaptability, resilience, collaboration, reimagining care delivery, and scaling early experiments play significant roles in the success of digital transformation. - Exciting times are ahead, and it's imperative to bring your A-game by preparing yourself as a next-generation digital leader: embrace a new set of skills while deepening the core competencies that have brought you this far, learn from industries that are ahead of healthcare in digital adoption, and lean into the change. This approach will enable you to navigate the complexities of digital transformation and drive impactful change in your organization.

35

6 Comments

Gen AI for biopharma: 5 less obvious truths Cognizant's Vyom Bhuta offers five core truths that companies can embrace to create value-driven, scalable generative AI programs and turn them into a multi-year competitive advantage. #biopharma #lifesciences #generativeAI

3

My esteemed colleague, Barry Heavey, Accenture Life Sciences Global lead for Supply Chain and Manufacturing, recently sat down with C.P.M. ContractPharma, sharing insights on how the pharma industry can leverage digital tools to reduce the rising costs of drug manufacturing. As the complexity of drug candidates continues to increase, so do manufacturing costs. Using AI and ML show promise in speeding up target identification, improving processes, and simplifying the supply chain. With these digital tools, companies can accelerate research and development, identify areas for improvement in manufacturing processes, and predict and prevent potential quality issues. They also can help reduce costs! If you’re interested in more details on the subject, check out the full article: https://lnkd.in/g_95V6uP

76

It is interesting to see how AI leadership takes shape in the healthcare industry. We're seeing organizations hire Chief AI Officers, while others have the CIO, data or digital leaders overseeing AI implementation. We're monitoring these trends. Here's our latest observations. https://lnkd.in/gX3yrDH9  

11

1 Comment

Rich Birhanzel, Accenture Global Health Industry Lead sat down with Xtelligent Healthcare on their podcast Healthcare Strategies to share his insights surrounding GenAI and workforce management at HIMSS 2024. The conversation focused on the potential of AI in healthcare, its responsible use, and privacy concerns. Birhanzel underscored the urgency of addressing the global crisis of patient access due to workforce shortages. He stressed the importance of automation through generative AI. However, this approach may require a cognitive shift as it will change providers' workflows, Birhanzel acknowledged. He emphasized the need for harmonization between technology and human workflows. Listen to the full podcast: https://lnkd.in/dF7cDzAS #genAI #workforcemanagement #podcast #talent 

30

2 Comments

By the third year of a major specialty retailer’s #costtransformation, they saw 45% revenue growth and 4X market capitalization growth. How can leaders achieve similar success in their cost programs? This article makes the case for viewing cost management as a strategic lever and outlines important considerations for doing so. https://on.bcg.com/4aKgR12

9

In 2023, Johnson & Johnson reinforced its position as a leading pharmaceutical company on the global stage. Through its vast network of resources and expertise, J&J demonstrated a remarkable ability to adapt, innovate, and respond to pressing healthcare challenges worldwide. Key Developments based on the 2023 Health for Humanity Report: Adaptive R&D Strategy: J&J's approach to research and development showcased its learning-oriented mindset. The company's breakthrough in multiple myeloma treatment with TALVEY, and advancements in lung cancer therapy with RYBREVANT, reflect its ability to rapidly translate scientific discoveries into practical therapies. These developments indicate J&J's commitment to continuous learning in oncology and haematology. Global Market Responsiveness: The expansion of the VELYS Robotic-Assisted Solution to 18 global markets demonstrates J&J's ability to learn from diverse healthcare systems and adapt its technologies to meet varying regulatory requirements and clinical needs. Cross-Disciplinary Innovation: J&J's progress in both pharma and medical device, as seen with the Monarch Platform's applications in urology and pulmonology, showcases the company's capacity to foster cross-pollination of ideas and technologies across different medical disciplines. Iterative Improvement in Patient Care: The introduction of the ETHIZIA Hemostatic Sealing Patch, which outperforms existing products, exemplifies J&J's commitment to iterative learning and improvement. J&J's ability to learn from diverse markets, integrate technologies across disciplines, and rapidly translate scientific discoveries into practical solutions sets a benchmark for the pharmaceutical industry. Joaquin Duato emphasized in a recent LinkedIn article the significance of fostering a receptive mindset when providing feedback. Recognizing that it can be difficult to receive feedback, he underlined the importance of ensuring individuals are in the right frame of mind to absorb and benefit from constructive guidance. By cultivating an environment that promotes open dialogue and continuous growth, J&J is well-positioned to fuel innovation and maximize its influence on global healthcare. Through previous collaborations with J&J, I have observed their consistent focus on innovation and continuous learning. In Innovative Medicine, Jennifer Taubert, Peter Lebowitz, and Craig Tendler have been pivotal in pioneering groundbreaking therapies and treatments that address unmet medical needs. In MedTech, Tim Schmid, Hani Abouhalka, and Peter Menziuso are leading the way with revolutionary technologies that are redefining surgical and diagnostic practices. As J&J continues to evolve, its learning-centric approach promises to yield even more groundbreaking advancements in healthcare, reinforcing its role as a global leader in pharma and medical technology innovation. #JNJ #Janssen #medtech #pharma #innovativemedicine

12

We interviewed 19 CPG CEOs to identify lessons on navigating uncertainty. Discover actionable insights on four essential themes in our latest white paper. #consumer #CPG   Learn why embracing technology innovations and proactive succession planning are crucial for CPG CEOs today. Dive into our report for more. #consumer #CPG

6

We expect further acceleration in job creation in the health care sector by the third quarter of this year, driven by the increasing adoption of #automation and #generativeAI technologies. Learn more in #TheRealEconomy blog: https://lnkd.in/gyqsv2XH

42

Closing the gap between people and technology in healthcare is now possible. Accenture's Rich Birhanzel shares three key challenges and insights on the importance of responsible AI in humanizing healthcare. #AIinHealthcare #FutureofHealthcare

27

EY leaders, Jerry Gootee and David Takeuchi break down the complex world of smart connected products in this insightful article. Learn how to leverage these tools for massive ROI. #AdvancedManufacturing #Technology #SmartConnectedProducts

1

1 Comment

Capturing hearts and minds is crucial." This powerful insight from Biogen's CFO, Mike McDonnell, stood out in our recent conversation.   In the latest installment of the Bold Advances in Health Care video series, Mike emphasized that their Fit-for-Growth initiative is all about engaging the entire team. By allowing teams to redesign their organizations from scratch, Biogen fostered creativity and commitment. This approach ensures that everyone is truly invested in the company’s success, making the transformation more effective and sustainable.   We also discussed Biogen's recent acquisitions, focusing on diversifying portfolios with the aim of improving patient outcomes, and the pivotal role AI will play in enhancing efficiency. Mike’s leadership philosophy and strategic insights offer valuable lessons in effective growth management. Listen to our full conversation here:https://lnkd.in/eAKj2VJW

58

1 Comment

We interviewed 19 CPG CEOs to identify lessons on navigating uncertainty. Discover actionable insights on four essential themes in our latest white paper. #consumer #CPG   Learn why embracing technology innovations and proactive succession planning are crucial for CPG CEOs today. Dive into our report for more. #consumer #CPG

36